Cross-Media Audience & Attention Measurement · AdTech Vendor · MarTech Vendor
Neurons
Predictive creative testing software based on neuroscience data.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Neurons Inc
- Entity type
- COMPANY
- Founded
- 2013
- Headquarters
- Høje Taastrup Boulevard 33, Tåstrup, Capital Region, 2630, DK
- Company size
- 50–200
- Market cluster / sector
- Cross-Media Audience & Attention Measurement
- Market role
- AdTech Vendor · MarTech Vendor
- Official website
- neuronsinc.com
What Neurons does
Neurons operates a B2B SaaS model centred on predictive creative analytics. It uses proprietary neuroscience and eye-tracking training data to produce attention heatmaps, behavioural scores, and optimisation recommendations for ad assets. Value is created by reducing creative testing time, improving campaign readiness before launch, and allowing customers to embed predictive insights into their own workflows through an API.
Category differentiation
This company is not a general-purpose AI model provider or a traditional market research panel business. It specialises in B2B predictive creative analytics based on neuroscience and attention data for advertising use cases.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Neurons is a Danish B2B software company that provides neuroscience-based creative testing and predictive analytics for advertising assets. Its core platform helps brands, agencies, and insights teams assess likely audience attention, engagement, and memory responses before campaigns go live, using models trained on long-running eye-tracking and brain-response datasets. The business generates revenue primarily from subscription access to its creative intelligence platform, with additional monetisation through enterprise-style API access, add-ons, and services such as workshops. Its customers are mainly advertiser marketing teams, media agencies, and technical analytics teams seeking to pre-test and optimise creative across digital channels without relying solely on live A/B testing.
Company news briefing
Briefing updated:
Neurons has expanded its predictive creative testing platform with the launch of Campaign Insights, providing consolidated performance reporting alongside enterprise tools designed to optimise creative assets prior to launch. Continuing its focus on ethical AI and governance, the company recently partnered with Kantar to test creative effectiveness myths and evaluate the drivers of brand impact using neuroscience data. These product and research initiatives further reinforce the firm's core proposition in attention tracking and B2B creative analytics.
Business model & monetisation
Neurons monetises primarily through tiered SaaS subscriptions for its core platform, with pricing tied to access level, usage, team configuration, and feature entitlements. It also uses add-on revenue from extra users, single sign-on, brand kits, and workshops. Its API likely adds enterprise licensing or usage-linked commercial terms for customers embedding predictive attention data into internal systems or partner products.
- Core creative intelligence platform
- SaaS subscription tiers
- API access
- Enterprise licensing or usage-based access
- Add-ons and workshops
- Service fees and feature upsells
Products & capabilities
No products with linked sources are available in this view.
Unlock Full Intelligence Profile for Neurons
Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.
Verified Ownership & Corporate Hierarchy
Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.
360° Tech Stack & Vendor Telemetry
Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.
Live Market Signals & Executive Briefings
Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Neurons's competitive landscape.
Predictive creative testing software for marketers and agencies.
Creative workflow SaaS with embedded predictive eye-tracking analytics.
Behavioural science SaaS for brand tracking and ad testing.
Privacy-native ad intelligence for programmatic media buying.
Attention-based advertising measurement and planning platform for marketers.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Introducing Campaign Insights
Recorded impact score: 2/5
Campaign Insights is new in Neurons: one report on what’s working across your campaign, and what to change next.
The New Rules of Creative Effectiveness: 5 Myths, Put to the Test
Recorded impact score: 2/5
Kantar and Neurons test five creative effectiveness myths. Discover what drives brand impact, sales, and creative bravery, plus how to use predictive AI.
How Enterprise Teams Optimize Creative Assets and Ads with Neurons
Recorded impact score: 2/5
See how enterprise teams use neuroscience-backed data to score, improve, and approve creative before launch, with fewer review rounds and stronger work.
Explore company relationships
Questions about Neurons
What is Neurons?
Neurons is a Danish B2B software company that helps advertisers and agencies pre-test and optimise ad creative using predictive neuroscience-based analytics.
Who uses Neurons?
Its users include brand marketing teams, media agencies, insights teams, developers, and analytics teams that evaluate advertising creative before launch.
How does Neurons make money?
It primarily earns revenue from tiered SaaS subscriptions, with additional income from API access, add-ons, and related workshops or enterprise services.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
18 publicly documented primary sources and citations linked across the market graph.
Continue your research on Neurons
Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Daily intelligent monitoring · Verified primary sources.
Unlock full intelligence profile, ownership & live market signals